Pensacola, Fla.-based Baptist Health Care has signed an agreement with Alpharetta, Ga.-based MedAssets to utilize MedAssets' tools to enhance operational efficiency.
Supply Chain
The U.S. Food and Drug Administration has approved Otezla (apremilast) for the treatment of psoriatic arthritis in adults.
The U.S. Food and Drug Administration has approved Xolair (omalizumab) to treat chronic idiopathic urticaria, a form of chronic hives, according to a news release.
Duderstadt, Germany-based Ottobock Healthcare announced plans to move its distribution and logistics operations to Louisville, Ky., according to a Louisville Business First report.
The U.S. Food and Drug Administration has approved Piramal Imaging's Neuraceq, a positron emission tomography imaging agent to aid in diagnosing dementia, according to a company news release.
Advertisement
The American Hospital Association is urging the U.S. Food and Drug Administration to take additional steps to alleviate the saline shortage.
The U.S. Food and Drug Administration has approved the first implantable hearing device geared toward adults who have severe or profound sensorineural hearing loss of high-frequency sounds but can still hear low-frequency sounds, either with or without a hearing aid.
The U.S. market for vascular access devices is projected to be worth more than $2 billion by 2022, according to a Decision Resources Group news release.
Mundelein, Ill.-based Medline has announced an agreement to purchase cleaning and disinfectant technologies from Niles, Ill.-based Medtrol, a sanitizer and disinfectant manufacturer.
Roseville, Calif.-based Adventist Health Hospitals has signed an agreement to use Aperek Ellipse, a spend visibility and analytics solution.